| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |